據HoldingsChannel.com報道，支流資本管理有限公司在第一季度減持了Zoetis股份(紐約證券交易所代碼：ZTS-GET評級)3.4%。該公司在此期間出售了130股后，擁有3640股該公司的股票。截至最近一個季度末，Attrary Capital Management LLC在Zoetis持有的股份價值68.6萬美元。
熱門資訊> 正文
支流資本管理有限責任公司減持Zoetis股票。
2022-07-06 21:21
Tributary Capital Management LLC reduced its position in shares of Zoetis Inc. (NYSE:ZTS – Get Rating) by 3.4% in the first quarter, HoldingsChannel.com reports. The firm owned 3,640 shares of the company's stock after selling 130 shares during the period. Tributary Capital Management LLC's holdings in Zoetis were worth $686,000 at the end of the most recent quarter.
Several other institutional investors have also recently bought and sold shares of the company. HNP Capital LLC boosted its holdings in shares of Zoetis by 4.5% during the fourth quarter. HNP Capital LLC now owns 1,165 shares of the company's stock worth $284,000 after purchasing an additional 50 shares during the period. Trust Co. of Vermont lifted its holdings in Zoetis by 4.9% in the fourth quarter. Trust Co. of Vermont now owns 1,090 shares of the company's stock worth $266,000 after buying an additional 51 shares during the period. Wade G W & Inc. lifted its holdings in Zoetis by 0.3% in the fourth quarter. Wade G W & Inc. now owns 17,654 shares of the company's stock worth $4,308,000 after buying an additional 53 shares during the period. Arete Wealth Advisors LLC lifted its holdings in Zoetis by 2.5% in the fourth quarter. Arete Wealth Advisors LLC now owns 2,200 shares of the company's stock worth $519,000 after buying an additional 54 shares during the period. Finally, Shorepoint Capital Partners LLC lifted its holdings in Zoetis by 0.9% in the fourth quarter. Shorepoint Capital Partners LLC now owns 6,273 shares of the company's stock worth $1,531,000 after buying an additional 54 shares during the period. Institutional investors own 90.73% of the company's stock.
其他幾家機構投資者最近也買賣了該公司的股票。HNP Capital LLC在第四季度將其持有的Zoetis股票增加了4.5%。HNP Capital LLC在此期間又購買了50股，現在擁有1,165股該公司股票，價值28.4萬美元。第四季度，佛蒙特州的Trust Co.增持了Zoetis 4.9%的股份。佛蒙特州的Trust Co.在此期間又購買了51股，目前持有1,090股該公司股票，價值266,000美元。Wade G W&Inc.在第四季度增持了Zoetis 0.3%的股份。Wade G W&Inc.現在持有17,654股該公司股票，價值4,308,000美元，在此期間又購買了53股。Arete Wealth Advisors LLC在第四季度增持了2.5%的Zoetis股份。Arete Wealth Advisors LLC在此期間又購買了54股，現在擁有2200股該公司股票，價值51.9萬美元。最后，Shorepoint Capital Partners LLC在第四季度將其在Zoetis的持股增加了0.9%。Shorepoint Capital Partners LLC現在擁有該公司6,273股股票，價值1,531,000美元，在此期間又購買了54股。機構投資者持有該公司90.73%的股票。
Get
到達
Zoetis
卓提斯
alerts:
警報：
Shares of ZTS opened at $174.25 on Wednesday. The company has a market capitalization of $82.01 billion, a P/E ratio of 39.97, a price-to-earnings-growth ratio of 2.93 and a beta of 0.73. The company has a quick ratio of 1.58, a current ratio of 2.25 and a debt-to-equity ratio of 1.12. The firm has a 50 day moving average of $167.62 and a 200 day moving average of $189.08. Zoetis Inc. has a twelve month low of $154.18 and a twelve month high of $249.27.
中興通訊股價周三開盤報174.25美元。該公司市值為820.1億美元，市盈率為39.97倍，市盈率為2.93倍，貝塔係數為0.73。該公司的速動比率為1.58，流動比率為2.25，債務權益比為1.12。該公司的50日移動均線切入位在167.62美元，200日移動均線切入位在189.08美元。Zoetis Inc.股價跌至154.18美元的12個月低點和249.27美元的12個月高點。
Zoetis (NYSE:ZTS – Get Rating) last announced its quarterly earnings results on Thursday, May 5th. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.10. The company had revenue of $2 billion during the quarter, compared to the consensus estimate of $1.98 billion. Zoetis had a net margin of 26.27% and a return on equity of 49.62%. The firm's quarterly revenue was up 6.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.26 earnings per share. On average, sell-side analysts expect that Zoetis Inc. will post 5.05 EPS for the current year.
Zoetis(紐約證券交易所代碼：ZTS-GET Rating)最近一次公佈季度收益是在5月5日星期四。該公司公佈本季度每股收益為1.32美元，比普遍預期的1.22美元高出0.10美元。該公司本季度營收為20億美元，而市場普遍預期為19.8億美元。Zoetis的淨利潤率為26.27%，股本回報率為49.62%。該公司的季度收入與去年同期相比增長了6.9%。去年同一季度，該公司每股收益為1.26美元。賣方分析師平均預計Zoetis Inc.本年度每股收益為5.05歐元。
The company also recently declared a quarterly dividend, which will be paid on Thursday, September 1st. Investors of record on Thursday, July 21st will be given a dividend of $0.325 per share. This represents a $1.30 annualized dividend and a dividend yield of 0.75%. The ex-dividend date is Wednesday, July 20th. Zoetis's dividend payout ratio (DPR) is currently 29.82%.
該公司最近還宣佈了季度股息，將於9月1日(星期四)支付。在7月21日(星期四)登記在冊的投資者將獲得每股0.325美元的股息。這意味着年化股息為1.30美元，股息收益率為0.75%。除息日期是7月20日星期三。Zoetis的股息支付率(DPR)目前為29.82%。
In other Zoetis news, EVP Roxanne Lagano sold 2,167 shares of Zoetis stock in a transaction that occurred on Tuesday, April 26th. The shares were sold at an average price of $178.96, for a total value of $387,806.32. Following the completion of the sale, the executive vice president now owns 23,687 shares of the company's stock, valued at approximately $4,239,025.52. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Willie M. Reed sold 1,855 shares of Zoetis stock in a transaction that occurred on Friday, June 10th. The stock was sold at an average price of $162.31, for a total transaction of $301,085.05. Following the completion of the sale, the director now directly owns 6,782 shares of the company's stock, valued at approximately $1,100,786.42. The disclosure for this sale can be found here. Insiders have sold 8,356 shares of company stock valued at $1,447,341 in the last three months. 0.12% of the stock is owned by insiders.
在Zoetis的其他新聞中，執行副總裁Roxanne Lagano在4月26日星期二的一筆交易中出售了2167股Zoetis股票。這些股票的平均價格為178.96美元，總價值為387,806.32美元。出售完成后，執行副總裁總裁現在持有該公司23,687股股票，價值約4,239,025.52美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的，該文件可在美國證券交易委員會網站上查閲。此外，董事威利·M·里德在6月10日(星期五)的一筆交易中出售了1,855股Zoetis股票。該股以162.31美元的平均價格出售，總成交金額為301,085.05美元。出售完成后，董事現在直接擁有該公司6,782股股票，價值約1,100,786.42美元。此次拍賣的披露信息可在此處找到。在過去的三個月里，內部人士已經出售了8,356股公司股票，價值1,447,341美元。0.12%的股份由內部人士持有。
ZTS has been the subject of several research analyst reports. The Goldman Sachs Group lowered their price objective on shares of Zoetis from $237.00 to $208.00 and set a "buy" rating for the company in a report on Thursday, May 19th. Stifel Nicolaus lowered their price objective on shares of Zoetis from $275.00 to $225.00 and set a "buy" rating for the company in a report on Friday, June 24th. StockNews.com lowered shares of Zoetis from a "strong-buy" rating to a "buy" rating in a report on Tuesday, April 26th. Finally, Citigroup lowered their target price on shares of Zoetis from $232.00 to $208.00 and set a "neutral" rating for the company in a report on Wednesday, March 9th. Two equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $229.75.
ZTS一直是幾份研究分析師報告的主題。高盛夫婦在5月19日周四的一份報告中將Zoetis的股票目標價從237.00美元下調至208.00美元，併爲該公司設定了「買入」評級。Stifel Nicolaus在6月24日(星期五)的一份報告中將Zoetis的股票目標價從275.00美元下調至225.00美元，併爲該公司設定了買入評級。在4月26日(星期二)的一份報告中，StockNews.com將Zoetis的股票評級從「強力買入」下調至「買入」。最后，花旗集團在3月9日周三的一份報告中將Zoetis的股票目標價從232.00美元下調至208.00美元，並將該公司的評級定為「中性」。兩名股票研究分析師將該股評級為持有，八名分析師給予該公司買入評級。根據MarketBeat.com的數據，該公司目前的普遍評級為「適度買入」，平均目標價為229.75美元。
Zoetis Company Profile (Get Rating)
Zoetis公司簡介(獲取評級)
Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.
Zoetis在美國和國際上發現、開發、製造動物保健藥物、疫苗和診斷產品，並將其商業化。它的產品主要是跨物種的，包括牲畜，如牛、豬、家禽、魚和羊；以及包括狗、貓和馬在內的同伴動物。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Zoetis (ZTS)
- 3 Home Improvement Stocks That Can Renovate Your Portfolio
- Get Defensive With These Three Upgrades
- Looking to Dump These 3 Possible Delisted Chinese Stocks? Let's Take a Look.
- Vera Bradley Stock Getting Cheap
- 3 Education Stocks to Enroll in This Summer
- 免費獲取StockNews.com關於Zoetis的研究報告(ZTS)
- 3只家裝類股，可以重塑你的投資組合
- 在這三個升級中保持防禦
- 想拋售這3只可能退市的中國股票嗎？讓我們來看看。
- 維拉·布拉德利的股票越來越便宜
- 3只教育類股將於今夏入圍
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Get Rating).
想看看其他對衝基金持有ZTS嗎？訪問HoldingsChannel.com獲取Zoetis的最新13F文件和內幕交易。
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.
接受Zoetis Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Zoetis和相關公司的最新新聞和分析師評級的每日簡要摘要。
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
